Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes

Diabetes Care

Volumn 35, Issue 11, 2012, Pages 2331-2336

  Conway, Baqiyyah N ^a   Aroda, Vanita R ^b   Maynard, John D ^c   Matter, Nathaniel ^c   Fernandez, Stephen ^d   Ratner, Robert E ^d   Orchard, Trevor J ^d  

^a VANDERBILT UNIVERSITY   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c VeraLight Inc   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CUTANEOUS PARAMETERS; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SKIN INTRINSIC FLUORESCENCE; UNITED STATES;

CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 84868119158     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0053     Document Type: Article

References (39)

1. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528-2538 (Pubitemid 44912266)
2. Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011;34:442-447
3. Rabbani N, Thornalley PJ. Glycation research in amino acids: a place to call home. Amino Acids 2012;42:1087-1096
4. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005;289:F645-F659 (Pubitemid 41324185)
5. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB. Diabetes and advanced glycoxidation end products. Diabetes Care 2006;29:1420-1432 (Pubitemid 44125953)
6. Vlassara H. Advanced glycation endproducts and atherosclerosis. Ann Med 1996;28:419-426
7. Meerwaldt R, Graaff R, Oomen PHN, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330 (Pubitemid 39093330)
8. Heikal AA. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anamolies. Biomarkers Med 2010;4:241-263
9. Na R, Stender IM, Ma L, Wulf HC. Autofluorescence spectrum of skin: component bands and body site variations. Skin Res Technol 2000;6:112-117 (Pubitemid 30459937)
10. Conway B, Edmundowicz D, Matter N, Maynard JD, Orchard T. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010;12:339-345
11. Conway BN, Aroda VR, Maynard JD, et al. Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care 2011;34:1000-1005
12. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990;13:741-747 (Pubitemid 20207423)
13. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
14. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Diabetes Care 2007;30:1120-1124 (Pubitemid 46684635)
15. Ediger MN, Olson BP, Maynard JD. Noninvasive optical screening for diabetes. J Diabetes Sci Tech 2009;3:776-780
16. Hull E, Ediger M, Unione A, Deemer E, Stroman M, Baynes J. Noninvasive, optical detection of diabetes: model studies with porcine skin. Opt Express 2004;12:4496-4510
17. Maynard J, Matter N, Olson B, Ediger M, Way J, Hull E. Noninvasive Pre-diabetes and Diabetes Screening Using Skin Fluorescence: Clinical Validation in an At-Risk Cohort. Canadian Journal of Diabetes. 2011;35:426
18. Atkinson AC. A note on the generalized information criterion for choice of a model. Biometrika 1980;67:413-418
19. Peppa M, Uribarri J, Vlassara H. Glucose, Advanced Glycation End Products, and Diabetes Complications: What is New and What Works. Clin Diabetes 2003;21:186-187
20. Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-842
21. Thomas MC, Forbes JM, MacIsaac R, Jerums G, Cooper ME. Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more? Ann N Y Acad Sci 2005;1043:644-654 (Pubitemid 41123955)
22. Uhlmann S, Rezzoug K, Friedrichs U, Hoffmann S, Wiedemann P. Advanced glycation end products quench nitric oxide in vitro. Graefes Arch Clin Exp Ophthalmol 2002;240:860-866 (Pubitemid 36075643)
23. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003;21:3-12 (Pubitemid 36143498)
24. Zhang L, Zalewski A, Liu Y, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003;108:472-478 (Pubitemid 36935542)
25. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 2007;72:S17-S26 (Pubitemid 47172557)
26. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605 (Pubitemid 44199649)
27. Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008;14:979-986 (Pubitemid 351753286)
28. Kilhovd BK, Juutilainen A, Lehto S, et al. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia 2007;50:1409-1417 (Pubitemid 46879016)
29. Ahmed N, Thornalley PJ, Lüthen R, et al. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 2004;41:913-919 (Pubitemid 39575657)
30. Conway B, Costacou T, Orchard T. Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? Diab Vasc Dis Res 2009;6:223-230
31. Shankar A, Klein R, Klein BE, Moss SE. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol 2007;166:393-402 (Pubitemid 47216790)
32. Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004;164:1917-1924 (Pubitemid 39274363)
33. Lutgers HL, Gerrits EG, Graaff R, et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009;52:789-797
34. Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 2009;17:162-168
35. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112 (Pubitemid 46052507)
36. Mulder DJ, van Haelst PL, Gross S, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2008;197:217-223 (Pubitemid 351273241)
37. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000;49:1571-1578
38. Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c) and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care 2011;34:1816-1820
39. Cleary P, Braffett B, Maynard J, et al. Association of skin intrinsic fluorescence with cumulative glycemic exposure in the DCCT/EDIC Study (Abstract). Diabetes 2011;54(Suppl. 1):S146